Hypertension in pregnancy: diagnosis and management
KEYWORDS: women, hypertension, pre-eclampsia, pregnancy, treatment, birth, committee, recommendations, antihypertensive, amended, risk, blood, evidence, care, gestational

continue antihypertensive treatment, if required (for choice of antihypertensive during the postnatal period, see the section on antihypertensive treatment during the postnatal period, including during breastfeeding) • offer a review of antihypertensive treatment 2 weeks after the birth, with their GP or specialist. [2010, amended 2019] 1.3.19 If a woman has taken methyldopa to treat chronic hypertension during pregnancy, stop within 2 days after the birth and change to an alternative antihypertensive treatment (for choice of antihypertensive during the postnatal period, see the section on antihypertensive treatment during the postnatal period, including during breastfeeding). [2010, amended 2019] 1.3.20 Offer women with chronic hypertension a medical review 6 to 8 weeks after the birth with their GP or specialist as appropriate. [2010, amended 2019] 1.4 Management of gestational hypertension Assessment and treatment of gestational hypertension 1.4.1 In women with gestational hypertension, a full assessment should be carried out in a secondary care setting by a healthcare professional who is trained in the management of hypertensive disorders of pregnancy. [2010, amended 2019] 1.4.2 In women with gestational hypertension, take account of the following risk factors that require additional assessment and follow-up: • nulliparity • age 40 years or older • pregnancy interval
